Ring Therapeutics
Gwen Buel, PhD, is a Senior Scientist at Ring Therapeutics with previous experience at The National Institutes of Health as a Research Fellow. Gwen also worked as a Lecturer at the Foundation for Advanced Education in the Sciences and as a Visiting Graduate Student at Weill Cornell Medical College. Before their professional career, Gwen earned a Ph.D. in Biological and Biomedical Sciences from Harvard University, following a B.S. in Biochemistry from the University of Vermont.
Ring Therapeutics
Ring Therapeutics' Anellogy™ platform aims to usher in a new era of gene therapy using the human commensal virome.